Clinical trial
Abciximab i.v. Versus i.c. in Primary PCI Patients With STEMI
NCT00299377 · University of Leipzig, Other · Completed
Key facts
| NCT number | NCT00299377 |
|---|---|
| Title | Abciximab i.v. Versus i.c. in Primary PCI Patients With STEMI |
| Official title | Randomized Comparison of Abciximab i.v. Versus i.c. in Primary PCI Patients With STEMI and Effects on Infarct Size and Microvascular Obstruction |
| Lead sponsor | University of Leipzig, Other |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Myocardial Infarction |
| Intervention type | Drug |
| Interventions | Abciximab i.v., Abciximab i.c. |
| Enrollment | 150 |
| Start date | Jan 1, 2006 |
| Primary completion | Nov 1, 2007 |
| Completion | Feb 1, 2008 |
| First posted | Mar 6, 2006 |
| Last update posted | Jul 3, 2008 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: